KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Invested Capital (2016 - 2025)

Historic Invested Capital for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $50.3 billion.

  • Medtronic's Invested Capital fell 411.56% to $50.3 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $50.3 billion, marking a year-over-year decrease of 411.56%. This contributed to the annual value of $51.1 billion for FY2025, which is 74.16% down from last year.
  • Latest data reveals that Medtronic reported Invested Capital of $50.3 billion as of Q4 2025, which was down 411.56% from $50.6 billion recorded in Q3 2025.
  • Medtronic's Invested Capital's 5-year high stood at $58.6 billion during Q3 2022, with a 5-year trough of $49.7 billion in Q3 2024.
  • Moreover, its 5-year median value for Invested Capital was $52.2 billion (2021), whereas its average is $53.0 billion.
  • In the last 5 years, Medtronic's Invested Capital soared by 1335.78% in 2022 and then crashed by 1141.67% in 2023.
  • Medtronic's Invested Capital (Quarter) stood at $52.2 billion in 2021, then rose by 11.01% to $57.9 billion in 2022, then fell by 8.52% to $53.0 billion in 2023, then dropped by 1.04% to $52.4 billion in 2024, then fell by 4.12% to $50.3 billion in 2025.
  • Its last three reported values are $50.3 billion in Q4 2025, $50.6 billion for Q3 2025, and $51.1 billion during Q2 2025.